FDA Drug recall D-0242-2021
Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind
- FDA Drug
- Class III
- terminated
- Published 2021-02-03
On 2021-02-03 the FDA classified a Class III recall of Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind by Sun Pharmaceutical Industries, citing incorrect Labeling: Incorrect lot number on secondary packaging.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0242-2021 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2021-01-11 |
| Published | 2021-02-03 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Sun Pharmaceutical Industries |
| Distribution | US |
Product
Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40
Reason
Incorrect Labeling: Incorrect lot number on secondary packaging
Identifiers
| ndc | 62756-017-40 |
|---|---|
| ndc | 62756-015-40 |
| ndc | 62756-016-40 |
| code_info | Lot JKX2553A |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0242-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.